CLASS III Drug recall · Reported 24 May 2017 · FDA Enforcement Report

Fluocinonide Cream UPS, 0.05% (Emulsified Base) recalled

Taro Pharmaceuticals U is recalling Fluocinonide Cream UPS, 0.05% (Emulsified Base), distributed nationwide in the US. The recall was initiated on 17 Mar 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: D301311473, D301411473, Exp 3/2017
NDC51672-1254, 51672-1253, 51672-1279, 51672-1264
UPC0351672126414, 0351672127923
Quantity recalled7,776 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0790-2017
FDA event ID
76837
Recalling firm
Taro Pharmaceuticals U, Hawthorne, NY
Manufacturer
Sun Pharmaceutical Industries, Inc.
Classification
Class III
Status
Terminated
Recall initiated
17 Mar 2017
FDA classified
18 May 2017
Reported
24 May 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

17 Mar 2017Recall initiated by company
18 May 2017Classified by FDA+62 days
24 May 2017Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3

Where it was distributed

U.S. Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.

Which lots are affected?

Lot #: D301311473, D301411473, Exp 3/2017

Where was it sold?

U.S. Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Taro Pharmaceuticals U

All 36

Other Fluocinonide recalls

All 11